pharma news, views and analysis - pharmaphorum.com

Trending

in News
AZ’s COVID jab tackles delta variant, but antibody fails clinical trial
June 15, 2021 Share
X
AZ’s COVID jab tackles delta variant, but antibody fails clinical trial
https://pharmaphorum.com/news/azs-covid-jab-tackles-delta-variant-but-antibody-fails-clinical-trial/
in News
J&J must ditch 60m COVID jabs made at US plant, but 10m are okay, says FDA
June 14, 2021 Share
X
J&J must ditch 60m COVID jabs made at US plant, but 10m are okay, says FDA
https://pharmaphorum.com/news/jj-must-ditch-60m-covid-jabs-made-at-us-plant-but-10m-are-okay-says-fda/

Latest News

US orders 500m Pfizer/BioNTech COVID jabs for developing nations

US orders 500m Pfizer/BioNTech COVID jabs for developing nations

The US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given

X

US orders 500m Pfizer/BioNTech COVID jabs for developing nations

https://pharmaphorum.com/news/us-orders-500m-pfizer-biontech/

Study links AstraZeneca COVID-19 shot to bleeding disorder ITP

Study links AstraZeneca COVID-19 shot to bleeding disorder ITP

Researchers in Scotland have identified a possible link between the Oxford University/AstraZeneca COVID-19 and a mostly mild and

X

Study links AstraZeneca COVID-19 shot to bleeding disorder ITP

https://pharmaphorum.com/news/study-links-astrazeneca-covid-19-shot-to-bleeding-disorder-itp/

Millions of COVID jabs risk being wasted, says UNICEF

Millions of COVID jabs risk being wasted, says UNICEF

Rich nations are being asked to start donating COVID-19 vaccines to other parts of the world straight away,

X

Millions of COVID jabs risk being wasted, says UNICEF

https://pharmaphorum.com/news/millions-of-covid-jabs-risk-being-wasted-says-unicef/

Views & analysis

Ensuring accessibility: Crossing the digital divide in healthcare

Ensuring accessibility: Crossing the digital divide in healthcare

“Rarely does the answer come from the boardroom” – what can user experience teach us about building accessible

X

Ensuring accessibility: Crossing the digital divide in healthcare

https://pharmaphorum.com/patients/ensuring-accessibility-crossing-the-digital-divide-in-healthcare/

Value-based healthcare: Pandemic learnings and future musings

Value-based healthcare: Pandemic learnings and future musings

In the second part of our series from the ‘Patient Experience: Empathy and Innovation’ Digital Summit, we look

X

Value-based healthcare: Pandemic learnings and future musings

https://pharmaphorum.com/views-and-analysis/value-based-healthcare-pandemic-learnings-and-future-musings/

Closing the feedback loop to drive patient experience improvements

Closing the feedback loop to drive patient experience improvements

Is collecting near real time data the key to unlocking improvements in patient experience and national benchmarking? Small

X

Closing the feedback loop to drive patient experience improvements

https://pharmaphorum.com/views-and-analysis/closing-the-feedback-loop-to-drive-patient-experience-improvements/

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

X

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Can simulated datasets unlock the potential of patient data?

Can simulated datasets unlock the potential of patient data?

Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development

X

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

Partner Content

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

Findings from patient research about severe asthma

X

Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma

https://pharmaphorum.com/partner-content/inhale-exhale-living-with-severe-asthma-and-severe-eosinophilic-asthma/

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

People living with chronic conditions remain cautious

X

People with Chronic Conditions Concerned About “Returning to Normal” During Pandemic

https://pharmaphorum.com/partner-content/people-with-chronic-conditions-concerned-about-returning-to-normal-during-pandemic/

The ALS patient journey

The ALS patient journey

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ALS is a progressive

X

The ALS patient journey

https://pharmaphorum.com/partner-content/the-als-patient-journey/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com